Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| MAPK signaling pathway | R-HSA-9652817 | map04010 | prednicarbate | 6714002 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | prednicarbate | 6714002 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | levopropoxyphene | 4906 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | levopropoxyphene | 4906 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | levopropoxyphene | 4906 | drug-path |
| Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | levopropoxyphene | 4906 | drug-path |
| VEGF signaling pathway | R-HSA-194138 | map04370 | levopropoxyphene | 4906 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | levopropoxyphene | 4906 | drug-path |
| Long-term depression | R-HSA-9620244 | map04730 | levopropoxyphene | 4906 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | meprylcaine | 3637 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | meprylcaine | 3637 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | meprylcaine | 3637 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | meprylcaine | 3637 | drug-path |
| VEGF signaling pathway | R-HSA-194138 | map04370 | meprylcaine | 3637 | drug-path |
| Melanogenesis | R-HSA-5662702 | map04916 | cyproterone | 5284537 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | cyproterone | 5284537 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | cyproterone | 5284537 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | cyproterone | 5284537 | drug-path |
| Wnt signaling pathway | R-HSA-195721 | map04310 | cyproterone | 5284537 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | cyproterone | 5284537 | drug-path |